podocalixina e anticorpo relacionado a tra, métodos de preparação e usos como agente terapêutico anticancerígeno
a invenção refere-se a um anticorpo ou um fragmento de ligação ao antígeno deste, incluindo uma cadeia pesada e uma cadeia leve, com regiões determinantes de complementaridade de cadeia pesada 1 a 3 tendo as sequências de aminoácidos de seq id nos. 1 a 3, respectivamente, e regiões determinantes de...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WILLIAM MICHAEL SCHOPPERLE YOUNGBIN TAK EDWIN SAAVEDRA TAN YAWEN JU AN MARY HOLMQVIST MATS HARALD HOLMQVIST |
| description | a invenção refere-se a um anticorpo ou um fragmento de ligação ao antígeno deste, incluindo uma cadeia pesada e uma cadeia leve, com regiões determinantes de complementaridade de cadeia pesada 1 a 3 tendo as sequências de aminoácidos de seq id nos. 1 a 3, respectivamente, e regiões determinantes de complementaridade de cadeia leve 1 a 3 tendo as sequências de aminoácidos de seq id nos. 4 a 6, respectivamente. além disso, a invenção refere-se a um agente terapêutico anticancerígeno incluindo o anticorpo ou o fragmento de ligação ao antígeno deste.
The invention relates to an antibody or an antigen-binding fragment thereof, including a heavy chain and a light chain, with heavy chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 1 to 3, respectively, and light chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 4 to 6, respectively. In addition, the invention relates to an anti-cancer therapeutic agent including the antibody or the antigen-binding fragment thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112018068637A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112018068637A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112018068637A23</originalsourceid><addsrcrecordid>eNqNjDsKAkEQRDcxEPUOnZgp7AfWTVUUYzFfmtlWBnanm_mA9zEQBU8xF3NED2BUUPXqjbMg3LHCXl-1QSBA47ViKwyWelSaDXYMCN7iAob48Al30BGIJUGL8R5vnH7BpVrxkNgLGU_gyaLEZ_jovlY0imx8pZmn2eiMvaPZLyfZfL87bQ9LEm7JCSoy5NvNsSjKvGjyuqmr1bqs_uXe2vZKbA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>podocalixina e anticorpo relacionado a tra, métodos de preparação e usos como agente terapêutico anticancerígeno</title><source>esp@cenet</source><creator>WILLIAM MICHAEL SCHOPPERLE ; YOUNGBIN TAK ; EDWIN SAAVEDRA TAN ; YAWEN JU ; AN MARY HOLMQVIST ; MATS HARALD HOLMQVIST</creator><creatorcontrib>WILLIAM MICHAEL SCHOPPERLE ; YOUNGBIN TAK ; EDWIN SAAVEDRA TAN ; YAWEN JU ; AN MARY HOLMQVIST ; MATS HARALD HOLMQVIST</creatorcontrib><description>a invenção refere-se a um anticorpo ou um fragmento de ligação ao antígeno deste, incluindo uma cadeia pesada e uma cadeia leve, com regiões determinantes de complementaridade de cadeia pesada 1 a 3 tendo as sequências de aminoácidos de seq id nos. 1 a 3, respectivamente, e regiões determinantes de complementaridade de cadeia leve 1 a 3 tendo as sequências de aminoácidos de seq id nos. 4 a 6, respectivamente. além disso, a invenção refere-se a um agente terapêutico anticancerígeno incluindo o anticorpo ou o fragmento de ligação ao antígeno deste.
The invention relates to an antibody or an antigen-binding fragment thereof, including a heavy chain and a light chain, with heavy chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 1 to 3, respectively, and light chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 4 to 6, respectively. In addition, the invention relates to an anti-cancer therapeutic agent including the antibody or the antigen-binding fragment thereof.</description><language>por</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190730&DB=EPODOC&CC=BR&NR=112018068637A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190730&DB=EPODOC&CC=BR&NR=112018068637A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WILLIAM MICHAEL SCHOPPERLE</creatorcontrib><creatorcontrib>YOUNGBIN TAK</creatorcontrib><creatorcontrib>EDWIN SAAVEDRA TAN</creatorcontrib><creatorcontrib>YAWEN JU</creatorcontrib><creatorcontrib>AN MARY HOLMQVIST</creatorcontrib><creatorcontrib>MATS HARALD HOLMQVIST</creatorcontrib><title>podocalixina e anticorpo relacionado a tra, métodos de preparação e usos como agente terapêutico anticancerígeno</title><description>a invenção refere-se a um anticorpo ou um fragmento de ligação ao antígeno deste, incluindo uma cadeia pesada e uma cadeia leve, com regiões determinantes de complementaridade de cadeia pesada 1 a 3 tendo as sequências de aminoácidos de seq id nos. 1 a 3, respectivamente, e regiões determinantes de complementaridade de cadeia leve 1 a 3 tendo as sequências de aminoácidos de seq id nos. 4 a 6, respectivamente. além disso, a invenção refere-se a um agente terapêutico anticancerígeno incluindo o anticorpo ou o fragmento de ligação ao antígeno deste.
The invention relates to an antibody or an antigen-binding fragment thereof, including a heavy chain and a light chain, with heavy chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 1 to 3, respectively, and light chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 4 to 6, respectively. In addition, the invention relates to an anti-cancer therapeutic agent including the antibody or the antigen-binding fragment thereof.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDsKAkEQRDcxEPUOnZgp7AfWTVUUYzFfmtlWBnanm_mA9zEQBU8xF3NED2BUUPXqjbMg3LHCXl-1QSBA47ViKwyWelSaDXYMCN7iAob48Al30BGIJUGL8R5vnH7BpVrxkNgLGU_gyaLEZ_jovlY0imx8pZmn2eiMvaPZLyfZfL87bQ9LEm7JCSoy5NvNsSjKvGjyuqmr1bqs_uXe2vZKbA</recordid><startdate>20190730</startdate><enddate>20190730</enddate><creator>WILLIAM MICHAEL SCHOPPERLE</creator><creator>YOUNGBIN TAK</creator><creator>EDWIN SAAVEDRA TAN</creator><creator>YAWEN JU</creator><creator>AN MARY HOLMQVIST</creator><creator>MATS HARALD HOLMQVIST</creator><scope>EVB</scope></search><sort><creationdate>20190730</creationdate><title>podocalixina e anticorpo relacionado a tra, métodos de preparação e usos como agente terapêutico anticancerígeno</title><author>WILLIAM MICHAEL SCHOPPERLE ; YOUNGBIN TAK ; EDWIN SAAVEDRA TAN ; YAWEN JU ; AN MARY HOLMQVIST ; MATS HARALD HOLMQVIST</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112018068637A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2019</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WILLIAM MICHAEL SCHOPPERLE</creatorcontrib><creatorcontrib>YOUNGBIN TAK</creatorcontrib><creatorcontrib>EDWIN SAAVEDRA TAN</creatorcontrib><creatorcontrib>YAWEN JU</creatorcontrib><creatorcontrib>AN MARY HOLMQVIST</creatorcontrib><creatorcontrib>MATS HARALD HOLMQVIST</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WILLIAM MICHAEL SCHOPPERLE</au><au>YOUNGBIN TAK</au><au>EDWIN SAAVEDRA TAN</au><au>YAWEN JU</au><au>AN MARY HOLMQVIST</au><au>MATS HARALD HOLMQVIST</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>podocalixina e anticorpo relacionado a tra, métodos de preparação e usos como agente terapêutico anticancerígeno</title><date>2019-07-30</date><risdate>2019</risdate><abstract>a invenção refere-se a um anticorpo ou um fragmento de ligação ao antígeno deste, incluindo uma cadeia pesada e uma cadeia leve, com regiões determinantes de complementaridade de cadeia pesada 1 a 3 tendo as sequências de aminoácidos de seq id nos. 1 a 3, respectivamente, e regiões determinantes de complementaridade de cadeia leve 1 a 3 tendo as sequências de aminoácidos de seq id nos. 4 a 6, respectivamente. além disso, a invenção refere-se a um agente terapêutico anticancerígeno incluindo o anticorpo ou o fragmento de ligação ao antígeno deste.
The invention relates to an antibody or an antigen-binding fragment thereof, including a heavy chain and a light chain, with heavy chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 1 to 3, respectively, and light chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 4 to 6, respectively. In addition, the invention relates to an anti-cancer therapeutic agent including the antibody or the antigen-binding fragment thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112018068637A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
| title | podocalixina e anticorpo relacionado a tra, métodos de preparação e usos como agente terapêutico anticancerígeno |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WILLIAM%20MICHAEL%20SCHOPPERLE&rft.date=2019-07-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112018068637A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |